secwatch.observer — SEC 8-K summary
======================================

Issuer:     Milestone Pharmaceuticals Inc. (MIST)
CIK:        0001408443
Form:       8-K
Filed at:   2022-07-08T23:59:59+00:00
Accession:  0001104659-22-078354
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Milestone Pharmaceuticals shareholders elect directors, approve auditor and equity plan amendment at 2022 meeting
--------------------------------------------------------------------------------

- All six director nominees elected: Joseph Oliveto, Lisa M. Giles, Richard Pasternak, Debra K. Liebert, Michael Tomsicek, Robert J. Wills. Votes for each ranged 19,105,725 – 19,110,012.
- PricewaterhouseCoopers LLP appointed as auditor for 2023 with 24,809,612 votes for, 0 against, 217,072 withheld.
- Amendment to 2019 Equity Incentive Plan approved; increase of 1,000,000 shares authorized. 15,462,071 for, 3,652,167 against, 5,912,446 broker non-votes.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1408443/000110465922078354/0001104659-22-078354-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1408443/000110465922078354/tm2220674d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-22-078354

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer